1 in 4 guideline authors have undisclosed links to drug companies
Those working on government-funded guidelines are much less likely to have undisclosed financial ties
Almost one in four of the researchers and clinicians who helped develop clinical guidelines have been found to have ties with big pharma that were not revealed at the time, an Australian study finds.
Health academic and writer Dr Roy Moynihan (PhD) and colleagues have examined the “potentially relevant” undisclosed financial ties between the health professionals who develop guidelines listed on the NHMRC’s database and pharmaceutical companies.
